• 1. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 2. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 3. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 4. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 5. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Phenylpyrazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazoles Phenylpyrazoles

Recent Advances in the Study of 1-(4-Methoxyphenyl)-4-methyl-1H-pyrazole (CAS: 1252572-49-8)

In recent years, the compound 1-(4-Methoxyphenyl)-4-methyl-1H-pyrazole (CAS: 1252572-49-8) has garnered significant attention in the field of chemical biology and pharmaceutical research. This heterocyclic compound, characterized by its pyrazole core and methoxyphenyl substituent, has shown promising potential in various therapeutic applications. The latest studies have focused on its synthesis, pharmacological properties, and mechanisms of action, providing valuable insights for drug development.

One of the key areas of research has been the optimization of synthetic routes for 1-(4-Methoxyphenyl)-4-methyl-1H-pyrazole. Recent publications highlight novel methodologies that improve yield and purity, such as microwave-assisted synthesis and catalytic cyclization techniques. These advancements not only enhance the scalability of production but also reduce environmental impact, aligning with the principles of green chemistry.

Pharmacological investigations have revealed that 1-(4-Methoxyphenyl)-4-methyl-1H-pyrazole exhibits notable anti-inflammatory and anticancer activities. In vitro and in vivo studies demonstrate its ability to modulate key signaling pathways, including the NF-κB and MAPK cascades. These findings suggest its potential as a lead compound for developing new therapeutics targeting chronic inflammatory diseases and certain types of cancer.

Furthermore, structural-activity relationship (SAR) studies have been conducted to explore modifications of the pyrazole scaffold. Researchers have identified specific functional groups that enhance bioactivity and selectivity, paving the way for the design of next-generation derivatives. Computational modeling and molecular docking simulations have also been employed to predict binding affinities and optimize drug-target interactions.

In addition to its therapeutic potential, 1-(4-Methoxyphenyl)-4-methyl-1H-pyrazole has been investigated for its role as a chemical probe in biological studies. Its ability to selectively inhibit certain enzymes and receptors makes it a valuable tool for elucidating complex biochemical pathways. This dual utility as both a therapeutic agent and a research tool underscores its versatility in the chemical biology landscape.

Despite these promising developments, challenges remain in the clinical translation of 1-(4-Methoxyphenyl)-4-methyl-1H-pyrazole. Issues such as bioavailability, metabolic stability, and potential off-target effects need to be addressed through further preclinical studies. Collaborative efforts between academia and industry will be crucial to overcoming these hurdles and advancing the compound toward clinical trials.

In conclusion, the latest research on 1-(4-Methoxyphenyl)-4-methyl-1H-pyrazole (CAS: 1252572-49-8) highlights its multifaceted potential in drug discovery and chemical biology. Continued exploration of its pharmacological properties and synthetic optimization will undoubtedly contribute to its future applications in medicine and scientific research.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)